CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of the period (in shares) at Dec. 31, 2022		88,108,000
Balance at beginning of the period at Dec. 31, 2022	$ 526,477	$ 881	$ 357,490	$ (100,025)	$ 268,551	$ (420)
Balance at beginning of the period (in shares) at Dec. 31, 2022				(1,677,000)
Increase (decrease) in stockholders equity
Stock-based compensation	29,800		29,800
Common stock issued under employee benefit plans (in shares)		546,000
Common stock issued under employee benefit plans	1,573	$ 5	1,568
Common stock withheld related to net share settlement of stock-based compensation (in shares)		(61,000)
Common stock withheld related to net share settlement of stock-based compensation	(2,481)		(2,481)
Other comprehensive income (loss)	(1,644)					(1,644)
Net income	169,885				169,885
Balance at end of the period (in shares) at Dec. 30, 2023		88,593,000
Balance at end of the period at Dec. 30, 2023	723,610	$ 886	386,377	$ (100,025)	438,436	(2,064)
Balance at end of the period (in shares) at Dec. 30, 2023				(1,677,000)
Increase (decrease) in stockholders equity
Stock-based compensation	40,719		40,719
Exercise of options (in shares)		634,000
Exercise of options	294	$ 6	288
Common stock withheld related to net share settlement of stock-based compensation (in shares)		(38,000)
Common stock withheld related to net share settlement of stock-based compensation	(1,463)		(1,463)
Repurchase of common stock, including excise tax (in shares)				(4,574,000)
Repurchase of common stock, including excise tax	(201,562)		(20,000)	$ (181,562)
Other comprehensive income (loss)	2,820					2,820
Net income	175,689				175,689
Balance at end of the period (in shares) at Dec. 28, 2024		89,189,000
Balance at end of the period at Dec. 28, 2024	$ 740,107	$ 892	405,921	$ (281,587)	614,125	756
Balance at end of the period (in shares) at Dec. 28, 2024	(14,960,656)			(6,251,000)
Increase (decrease) in stockholders equity
Stock-based compensation	$ 47,688		47,688
Exercise of options (in shares)	0
Common stock issued under employee benefit plans (in shares)		811,000
Common stock issued under employee benefit plans	$ 0	$ 8	(8)
Common stock withheld related to net share settlement of stock-based compensation (in shares)		(48,000)
Common stock withheld related to net share settlement of stock-based compensation	(1,831)		(1,831)
Repurchase of common stock, including excise tax (in shares)				(8,710,000)
Repurchase of common stock, including excise tax	(300,681)		20,000	$ (320,681)
Other comprehensive income (loss)	(394)					(394)
Net income	165,387				165,387
Balance at end of the period (in shares) at Jan. 03, 2026		89,952,000
Balance at end of the period at Jan. 03, 2026	$ 650,276	$ 900	$ 471,770	$ (602,268)	$ 779,512	$ 362
Balance at end of the period (in shares) at Jan. 03, 2026	(14,960,656)			(14,961,000)